Matt Gline, Roivant Sciences CEO (Photo by John Sciulli/Getty Images for GLG)
Pfizer and Roivant team up again for another 'Vant', setting up anti-inflammatory showdown with Prometheus
Pfizer and Roivant are teaming up to launch a new ‘Vant’ aimed at bringing a mid-stage anti-inflammatory drug to market, the pair announced Thursday. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
